Psychobiology of Stress and Alcohol Craving

Sponsor
Central Institute of Mental Health, Mannheim (Other)
Overall Status
Recruiting
CT.gov ID
NCT03810950
Collaborator
Project Group for Automation in Medicine and Biotechnology PAMB, Mannheim (Other)
20
1
2
29.9
0.7

Study Details

Study Description

Brief Summary

In this feasibility study the investigators are using a setup of stress-related body sensors including established as well as innovative sensor-based measures to identify predictor profiles for alcohol-related behavioral and neural measures in Alcohol Use Disorder (AUD). Long-term aim is the definition of a setup of mobile sensors and their integration in a mobile infrastructure that allows the prediction of stress related alcohol intake in an ambulatory setting.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Trier Social Stress Test
  • Behavioral: Reading Newspaper
  • Behavioral: Barlab-Exposure
N/A

Detailed Description

The long-term aim is the definition of a setup of mobile sensors and their integration in a mobile infrastructure that allows the prediction of stress related alcohol intake in an ambulatory setting.

In patients with Alcohol Use Disorder (AUD) stress exposure is known to affect craving, cue-reactivity and relapse risk. Here, the investigators aim to identify stress- and alcohol cue-related physiological markers in a lab experiment to assess interactions between acute psychological stress exposure and alcohol cue-exposure regarding their effects on alcohol craving and related markers (attentional bias to alcohol-cues, implicit association task, neural cue-reactivity). In addition to applying established stress-related markers (cortisol in saliva, heart-rate variability, systolic blood pressure and electrodermal activity), the investigators will integrate innovative measures currently under investigation (e.g. voice stress analysis) to identify whether these additional parameters increase the predictive significance.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Physiological, Neural and Behavioral Correlates of Psychosocial Stress and Alcohol Craving
Actual Study Start Date :
Jan 1, 2019
Anticipated Primary Completion Date :
Jun 30, 2021
Anticipated Study Completion Date :
Jun 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Social Stress Test

Participants undergo the Trier Social Stress Test before Barlab-Exposure

Behavioral: Trier Social Stress Test
Test to induce high levels of acute social stress, including actors and a faked exam situation

Behavioral: Barlab-Exposure
Participants are exposed to a bar situation with different sorts of alcohol available. They sniff at water and at one alcoholic drink.

Active Comparator: Control Condition

Participants reads newspaper before Barlab-Exposure

Behavioral: Reading Newspaper
Participants read newspaper

Behavioral: Barlab-Exposure
Participants are exposed to a bar situation with different sorts of alcohol available. They sniff at water and at one alcoholic drink.

Outcome Measures

Primary Outcome Measures

  1. change in heart rate [at examination day: continuous measurement throughout the whole experiment (except during MRI scanning); duration around 2 hours; starting 1 hour 50 minutes after arrival of the proband]

    heart rate acquired with ear clip (continuous time series)

  2. change in heart rate variability [at examination day: continuous measurement throughout the whole experiment (except during MRI scanning); duration around 2 hours; starting 1 hour 50 minutes after arrival of the proband]

    heart rate variability acquired with ear clip (continuous time series)

  3. change in blood pressure (systolic and diastolic) [at examination day: 6 time points measured throughout the whole experiment (except during MRI scanning); at 2:20h, 2:50h, 3:20h, 3:50h, 4:50h, 5:05h after arrival of the proband]

    acquired with pressure sleeve

  4. change in electrodermal activity [at examination day: continuous measurement throughout the whole experiment (except during MRI scanning); duration around 2 hour; starting 1h 50min after arrival of the proband]

    time series acquired with body sensor

  5. neural alcohol-related cue-reactivity [at examination day: measured directly after the behavioral tasks at the end of the lab experiment]

    % signal change, measured with fMRI; paradigm Vollstädt-Klein et al. 2010 [% signal change is not a change over time; it is measured during one experimental session]

  6. neural inhibition processing [at examination day: measured directly after the behavioral tasks at the end of the lab experiment]

    % signal change, measured with fMRI; stop-signal reaction time task (Fauth-Buhler et al. 2012) [% signal change is not a change over time; it is measured during one experimental session]

  7. neural emotion processing [at examination day: measured directly after the behavioral tasks at the end of the lab experiment]

    % signal change, measured with fMRI; faces task (Hariri et al. 2002) [% signal change is not a change over time; it is measured during one experimental session]

  8. resting state activity [at examination day: measured directly after the behavioral tasks at the end of the lab experiment]

    resting state connectivity measured with fMRI

  9. attentional bias to alcohol cues [at examination day: measured directly after the stress task / newspaper reading; before "implicit alcohol association" and MRI session]

    measured with reaction time differences (in milliseconds) using the dotprobe-task (Vollstädt-Klein et al. 2009) [reaction time differences is not a change over time; it is measured during one experimental session]

  10. implicit alcohol association [at examination day: measured after the stress task / newspaper reading, directly after the "attentional bias to alcohol cues" ; before MRI session]

    measured with reaction time differences (in milliseconds) using the implicit association task (Wiers et al. 2016) [reaction time differences is not a change over time; it is measured during one experimental session]

  11. change in level of cortisol [at examination day: 6 time points measured throughout the whole experiment (except during MRI scanning); at hours:minutes 2:20, 2:50, 3:20, 3:50, 4:50, 5:05 after arrival of the proband]

    cortisol measured in saliva as a stress marker

  12. change in voice stress pattern [at examination day: 6 time points measured throughout the whole experiment (except during MRI scanning); at hours:minutes 2:20, 2:50, 3:20, 3:50, 4:50, 5:05 after arrival of the proband]

    audio file of participants' voice for voice stress pattern analysis will be recorded. From this a multivariate measure (i.e. multivariate vector) will be acquired (including frequency, loudness etc.)

  13. change in alcohol urges [at examination day: 6 time points measured throughout the whole experiment (except during MRI scanning); at hours:minutes 2:20, 2:50, 3:20, 3:50, 4:50, 5:05 after arrival of the proband]

    elf-report questionnaire: "Alcohol Urge Questionnaire (AUQ)"; Bohn et al. 1995

  14. change in alcohol craving [at examination day: 6 time points measured throughout the whole experiment (except during MRI scanning); at hours:minutes 2:20, 2:50, 3:20, 3:50, 4:50, 5:05 after arrival of the proband]

    self-report "How strong is your craving for alcohol?": reported on a visual analogue scale ranging from 0 to 100

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Heavy drinking, defined by alcohol consumption of at least 20g alcohol per day (at 5 days per week)

  • sufficient ability to communicate with the investigators, to answer questions in oral and written form

  • fully informed consent

  • written informed consent

Exclusion Criteria:
  • withdrawal of the declaration of consent

  • positive urin drug screening (cannabis, amphetamine, opiates, benzodiazepines, cocaine)

  • Lifetime history of DSM-5 bipolar disorder, schizophrenia or schizophrenia spectrum disorder, or substance dependence other than alcohol or nicotine or cannabis dependence.

  • Current threshold DSM-5 diagnosis of major depressive disorder, or presence of suicidal intention

  • History of severe head trauma or other severe central nervous system disorder (e.g., dementia, Parkinson's disease, multiple sclerosis)

  • Current use of medications or drugs known to interact with the CNS within at least four half-lives post last intake

Contacts and Locations

Locations

Site City State Country Postal Code
1 Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit Mannheim Germany

Sponsors and Collaborators

  • Central Institute of Mental Health, Mannheim
  • Project Group for Automation in Medicine and Biotechnology PAMB, Mannheim

Investigators

  • Principal Investigator: Sabine Vollstädt-Klein, Prof. Dr., Central Institute of Mental Health, Mannheim

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Central Institute of Mental Health, Mannheim
ClinicalTrials.gov Identifier:
NCT03810950
Other Study ID Numbers:
  • TRR265 A03-Pilot
First Posted:
Jan 22, 2019
Last Update Posted:
Dec 30, 2020
Last Verified:
Dec 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 30, 2020